Tocopherols are essential micronutrients for mammals widely known as potent lipid-soluble antioxidants that are present in cell membranes. Recent studies have demonstrated that most of the carboxychromanol (CEHC), a tocopherol metabolite, in the plasma exists primarily in sulfate-and glucuronide-conjugated forms. To gain insight into the enzymatic sulfation of tocopherols and their metabolites, a systematic investigation was performed using all 14 known human cytosolic sulfotransferases (SULTs). The results showed that the members of the SULT1 family displayed stronger sulfating activities toward tocopherols and their metabolites. These enzymes showed a substrate preference for -tocopherol over -tocopherol and for -CEHC over other CEHCs. Using A549 human lung epithelial cells in a metabolic labeling study, a similar trend in the sulfation of tocopherols and CEHCs was observed. Collectively, the results obtained indicate that SULTmediated enzymatic sulfation of tocopherols and their metabolites is a significant pathway for regulation of the homeostasis and physiological functions of these important compounds.
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Key words: cytosolic sulfotransferase (SULT); tocopherol; carboxyethyl-hydroxychroman (CEHC); sulfation Vitamin E is synthesized exclusively by plants and is an essential micronutrient for mammals, including humans. It is a potent lipid-soluble antioxidant present in cell membranes and lipoproteins, and it plays an important role in protecting cells from oxidative damage caused by free radicals. In addition to its antioxidant activity, vitamin E can be involved in biochemical and physiological processes such as modulation of cellular signaling and gene expression. 1) In nature, there are eight structurally related forms of vitamin E, including -, -, -, and -tocopherol and four corresponding tocotrienols. Tocopherols in general contain a chromanol ring and a 13-carbon hydrophobic side chain, which are responsible for their potent antioxidant activity and lipophilicity respectively (Fig. 1) .
Although -tocopherol is the major form, produced in many dietary plant seeds, the most abundant form of vitamin E, found in the circulation and in almost all tissues in the body, is -tocopherol.
2) Apart from the selectivity due to -tocopherol transfer protein (-TTP) binding to -tocopherol, the other forms of tocopherol are metabolized via the cytochrome P450 (CYP)-mediated pathway. CYP-mediated metabolism of vitamin E is an important pathway for the homeostasis of vitamin E because it has been found that inhibition of CYP-dependent vitamin E metabolism by sesame lignans, e.g., ketoconazole, in rats increases plasmatocopherol to levels approaching those of -tocopherol.
3)
CYP-mediated metabolism involves initial CYP4F2-and/or CYP3A-catalyzed hydroxylation of a terminal methyl group at the 13 0 position of the phytyl tail, followed by dehydrogenation and stepwise removal of the 2-or 3-carbon moieties by -oxidation. As the final product, the 3 0 -carboxychromanol metabolite (CEHC) of the parent tocopherol is formed. 4) This is subsequently released into the plasma. Recent studies have found that -CEHC, a CEHC, has natriuretic activity and antiinflammatory effects, and thus may have potential for use as a pharmaceutical agent. 5) In addition, it has been found that 88-98% of plasma -CEHC is conjugated by sulfation or glucuronidation. 6, 7) The presence of high levels of conjugated CEHCs in the plasma indicates that a high degree of conjugation reactions may occur in the liver upon the generation of CEHCs. However, the enzymes involved in the conjugation reactions have not yet been identified, and the chemical nature of the conjugated forms of the vitamin E metabolites remains to be fully characterized.
Sulfate conjugation, a major phase II reaction, is an important pathway in the biotransformation and excretion of numerous drugs and xenobiotics, as well as endogenous compounds such as catecholamines, steroids, thyroid hormones, and bile acids.
8 12) Both SULT1C2 and SULT1C4 catalyze the sulfation of xenobiotics such as pnitrophenol and N-hydroxy-2-acetylaminofluorene. 13) SULT1E1 is mainly expressed in the liver and endometrium. It catalyzes the sulfation of estrogenic compounds, with high affinity for 17-estradiol.
14) The SULT2 family includes three distinct enzymes (SULT2A1, SULT2B1a, SULT2B1b), which catalyze the sulfation of steroid hormones such as dehydroepiandrosterone, pregnenolone, and cholesterol. 15, 16) SULT4A1 is expressed primarily in the brain and peripheral neuronal tissues, and is highly conserved across vertebrate species. No endogenous or exogenous substrate, however, has been identified for SULT4A1. 17) SULT6B1 is expressed in the testes of primates at the mRNA level, but neither the protein nor its enzymatic activity have been characterized. 12, 18) Here, we report a systematic investigation of the sulfation of a panel of vitamin E-related compounds by all known human SULT isoforms. The kinetic parameters of relevant SULTs, particularly SULT1A1, in the sulfation of CEHCs were determined. Moreover, analyses of the expression of tocopherol-sulfating SULTs and the sulfation of CEHCs, under metabolic settings, by cultured human lung epithelial (A549) cells were performed.
Materials and Methods
Materials. -Tocopherol was purchased from Wako Pure Chemicals (Osaka, Japan). -Tocopherol, -tocopherol, and trolox (an -CEHC analog) were from Sigma Aldrich (St. Louis, MO, USA).
-CEHC, -CEHC, -CEHC, and -CMBHC (5-(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl)-pentanoic acid) were from Cayman Chemical. Isopropyl -D-thiogalactopyranoside (IPTG) was from Takara (Shiga, Japan). The BL21 Escherichia coli host strain was from Stratagene (La Lolla, CA, USA). pGEX-4T-1, -4T-2, and -2TK prokaryotic GST fusion vectors and glutathione sepharose 4B were from Amersham Biosciences (Piscataway, NJ, USA). Cellulose and silica gel thin-layer chromatography (TLC) plates were from Merck (Darmstadt, Germany). All other chemicals were of the highest grade commercially available.
Bacterial expression and purification of recombinant human cytosolic SULTs. pGEX-4T-1, -4T-2, or -2TK harboring cloned human SULTs cDNAs, SULT1A1 (GenBank ID NP 001046), SULT1A2 (NP 001045), SULT1A3 (NP 808220), SULT1B1 (NP 055280), SULT1C1a (NP 001008743), SULT1C1b (DAA01770), SULT1C2 (NP 001047), SULT1C4 (NP 006579), SULT1E1 (NP 005411), SULT2A1 (NP 003158), SULT2B1a (NP 004596), SULT2B1b (NP 814444), SULT4A1 (NP 055166), and SULT6B1 (NP 001027549), were individually transformed into competent E. coli BL21 cells. These cells were grown to OD 600 nm ¼ 0:3 in 100 mL of LB medium supplemented with 100 mg/mL of ampicillin, and were induced with 0.1 mM IPTG. After 12 h of induction at room temperature, the cells were collected by centrifugation and homogenized in 15 mL of ice-cold lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, and 1 mM EDTA) using a French Press (Ohtake, Tokyo, Japan). The crude homogenate was subjected to centrifugation at 20;400 Â g for 15 min at 4 C. The supernatant collected was fractionated using 0.5 mL of glutathione Sepharose 4B, and the bound GST fusion protein was treated with 0.5 mL of a thrombin digestion buffer (50 mM TrisHCl pH 8.0, 150 mM NaCl, and 2.5 mM CaCl 2 ) containing 5 units/mL of bovine thrombin. Following 2 h of incubation at 4 C with constant agitation, the preparation was subjected to centrifugation, and the supernatant containing purified recombinant SULT was collected and used in the enzymatic assay.
Enzymatic assay. The sulfating activity of human SULTs was assayed using 35 S-PAPS as the sulfate donor. The standard assay mixture, at a final volume of 25 mL, contained 50 mM sodium phosphate buffer pH 7.5, 0.2 mM 35 S-PAPS (45 Ci/mmol), and 100 mM substrate. The reaction started by the addition of the enzyme, was allowed to proceed for 30 min at 37 C, and was terminated by heating at 100 C for 3 min. The precipitates formed were removed by centrifugation, and the supernatant was subjected to analysis of the 35 S-sulfated product using a previously developed TLC separation procedure, 19) with n-butanol/isopropanol/formic acid/water (3:1:1:1 by volume) as the solvent system. Then the air-dried plate was analyzed using a Fluoro Image Analyzer FLA-3000 (Fujifilm, Tokyo, Japan). For kinetic studies of the sulfation of CEHCs, the kinetic parameters of human SULT1A1 for CEHCs were determined using final substrate concentrations ranging from 1 mM to 250 mM. The data obtained were processed using the Excel program to generate the bestfit trendline for the Lineweaver-Burk plots.
Cell culture. A549 human lung epithelial cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL of penicillin, and 100 mg/mL of streptomycin at 37 C in a humidified atmosphere containing 5% CO 2 .
Metabolic labeling of A549 cells with 35 S-sulfate in the presence of tocopherols or tocopherol metabolites. A549 cells were grown to 80% confluency in the individual wells of a 24-well culture plate, preincubated in sulfate-free MEM for 6 h, and were labeled with 0.2-mL aliquots of the same medium containing 35 S-sulfate (1 mCi/mL), and 10 mM tocopherols, CEHCs, -CMBHC, or trolox. At the end of a 48-h labeling period, the labeling media were collected and centrifuged and the supernatants were analyzed by TLC, followed by FLA-3000.
Miscellaneous methods. To prepare solutions for use in enzymatic assay and metabolic labeling experiments, tocopherols were first dissolved in dimethyl sulfoxide (DMSO) and then diluted in fatty acidfree bovine serum albumin (10 mg/mL). The CEHCs, -CMBHC, and trolox were dissolved in DMSO.
35 S-PAPS (45 Ci/mmol) was synthesized from ATP and 35 S-sulfate using recombinant human bifunctional ATP sulfurylase/adenosine 5 0 -phosphosulfate kinase, as described previously. 20) Protein determination was performed based on Lowry's method, with bovine serum albumin as the standard.
21)

Results and Discussion
While a majority of the studies carried out since the discovery of vitamin E have focused primarily on the antioxidant properties of tocopherols, some recent studies have looked into additional functions of tocopherol metabolites, including -CEHC. -CEHC, and the other CEHCs, present in tissues or excreted in the urine, have been found to be present in conjugated forms, such as sulfated and glucuronidated esters. 22, 23) To date, however, there has been no information concerning the sulfation of vitamin E and its metabolites, including CEHCs. To deal with this important issue, we performed a systematic investigation using all 14 human SULT enzymes, with tocopherols and their metabolites as substrates.
Sulfation of tocopherols and tocopherol metabolites by human SULTs
As shown in Table 1 , of the 14 human SULTs tested, four members of the SULT1 family, SULT1A1, SULT1B1, SULT1C4, and SULT1E1, displayed considerably higher activity than the other 10 SULTs toward tocopherols and their metabolites. However, seven tested SULTs (SULT1C1a, SULT1C1b, SULT1C2, SULT2B1a, SULT2B1b, SULT4A1, and SULT6B1) did not display any activity toward vitamin E-related substrates. For the sake of clarity, the details of the results are divided into three parts concerning, tocopherol sulfation, CEHC sulfation, and -tocopherol metabolite sulfation.
Tocopherol sulfation
Four human SULT1 enzymes, SULT1A1, SULT1B1, SULT1C4, and SULT1E1, showed specific activities, in decreasing order, for -tocopherol, -tocopherol, and -tocopherol. For humans, -tocopherol is the predominant form of vitamin E, is found in various tissues, and is the least catabolized among the tocopherols. In contrast, non-forms, such as -and -tocopherols, are more likely to be metabolized and excreted in the urine and bile. In the liver, therefore, SULTs might preferentially sulfate non-forms of tocopherol and facilitate the excretion of their metabolites. That tocopherols were sulfated by human SULTs, as mentioned above, in spite of their low water-solubility, indicates that tocopherols have an appropriate structure for sulfation in vitro. In vivo, however, tocopherols are normally present in non-cytosolic compartments such as membranes, lipid droplets, or vesicles, or are bound to proteins such as -TTP. Whether tocopherols can be sulfated in vivo thus remains to be clarified.
CEHC sulfation
The four human SULT1 enzymes listed above showed higher specific activities for -CEHC than for other CEHCs. This is in accord with the fact that conjugated -CEHC is the most abundant form of all vitamin E metabolites in the plasma, and that non-conjugated -CEHC appears to be a minor metabolite. 6, 7) Of the four SULTs, SULT1C4 showed the highest activity for all CEHCs. Previous studies have found that SULT1C4 is expressed in the fetal kidney and lung at the mRNA level. While the physiological relevance of CEHC sulfation remains to be determined, it is possible that SULT1C4 plays a role in regulating CEHC concentrations for yet-to-be-clarified functions during the development of the human fetus. It was noted that while the sulfating activities of SULT1B1 and SULT1C4 for -CEHC were higher than those for -CEHC, the activities of SULT1A1 and SULT1E1 for -CEHC were comparable to those for -CEHC. These results suggest that different SULT enzymes have differential substrate Specific activity refers to pmol of sulfated product formed/min/mg the enzyme. The data shown represent means AE SD for three determinations. N.D., not detected.
specificities for different CEHCs, and that different CEHCs are metabolized by distinct SULT enzymes present in different tissues.
Sulfation of -tocopherol metabolites
Of the four human SULT1 enzymes listed above, SULT1A1, SULT1B1, and SULT1C4 showed higher sulfating activities toward -CMBHC, a 5 0 -carboxychromanol (5 0 -COOH) analog, than for -CEHC. The sulfating activity of SULT1C4 for -CMBHC was about 5-fold higher than that for -CEHC. These results indicate that carboxychromanols including long-and short-chain metabolites are sulfated at different levels. A recent study identified 13 0 -COOH as a novel competitive inhibitor of cyclooxygenase-2 (COX2), which can inhibit COX2 much more potently than vitamin E or shorter-chain carboxychromanols.
24) The extent of sulfation of carboxychromanols might be associated with their anti-inflammatory effects. Further study of the sulfation of all vitamin E metabolites is necessary in order to understand these pathways fully. The above-mentioned results, nevertheless, appear to support the hypothesis that sulfation occurs in parallel with -oxidation during tocopherol metabolism. Unlike the other three SULTs, SULT1E1 showed higher specific activity for -CEHC than for -CMBHC. This latter finding suggests that SULT1E1 can metabolize shorter-chain carboxychromanols better than long-chain ones.
Kinetic parameters
Kinetic parameters V max , K m , and V max =K m for the sulfation of CEHCs, -CMBHC, or trolox by SULT1A1 were determined based on Lineweaver-Burk plots ( Table 2 ). The results in Table 2 indicate that the apparent K m of SULT1A1 for -CEHC was 78.4 mM, and that the V max value was 833.3 pmol/min/mg the enzyme. The apparent K m values for the other CEHCs were considerably higher and the V max =K m values were much lower than the values for -CEHC. These results appear to be in line with the higher abundance of conjugated -CEHC observed in human urine than -CEHC. 25) Previous studies have found that the concentration of -CEHC sulfate is about À10 mM in the plasma of rats after -tocopherol or -tocotrienol supplementation.
7) It is possible that the sulfation of -CEHC within this concentration range proceeds as a first-order reaction that occurs proportionately to increasing concentrations of -CEHC. In the sulfation of -tocopherol metabolites, catalytic efficiency, as reflected by V max =K m , of -CMBHC, for example, was twice as high as that for -CEHC. These results suggest that not all shorter-chain carboxychromanols are sulfated efficiently compared to long-chain carboxychromanols. The sulfating activity for carboxychromanols thus might be independent of the water-solubility of these compounds.
Use of A549 human lung epithelial cells in metabolic study of the sulfation of tocopherol metabolites A previous study found that A549 cells, possibly because of the high level of tocopherol-!-hydroxylase activity associated with CYP4F2, are capable of metabolizing tocopherols and of generating significantly higher amounts of tocopherol metabolites than HepG2 (human liver carcinoma) cells. 26) Moreover, sulfated carboxychromanols have been detected in A549 cells incubated in the presence of tocopherols. 27) Hence we decided to use A549 cells to investigate further the sulfation of tocopherol metabolites under metabolic conditions.
To clarify the SULT isoforms expressed in A549 cells, RT-PCR analysis was done. The results indicated that in A549 cells, SULT1A, SULT1C2, SULT2B1a, and SULT2B1b are expressed, but SULT1C2, SULT2B1a, and SULT2B1b had no sulfating activity against any vitamin E-related substrates. Therefore, SULT1A might account in the main for the capacity of A549 cells to sulfate vitamin E-related compounds (data not shown).
Generation and release of
35 S-sulfated tocopherol metabolites by A549 cells metabolically labeled with 35 S-sulfate
Following confirmation of the expression of SULT1A in the A549 cells, we proceeded to examine their capacity to sulfate tocopherol metabolites. As shown in Fig. 2 , the A549 cells incubated with -CEHC showed the highest release of -CEHC sulfate into the spent culture medium. Compared to the cells incubated with -tocopherol or -tocopherol, the cells incubated with -tocopherol did not produce any detectable amounts of sulfated metabolites into the medium. These results suggest that once -and -tocopherol enter cells, they are extensively metabolized to the corresponding carboxychromanols by CYP4F2, followed by stepwise -oxidation by peroxisomal and mitochondrial enzymes, 28) and are eventually sulfated by SULT1A. On the other hand, since -tocopherol was found to be the least metabolized, it might be retained within the cell membranes without being sulfated. These results are in accordance with previous observations for HepG2 cells. 29) To summarize, we made a systematic study of the sulfation of tocopherols and their metabolites by human SULT isoforms. We found for the first time that members of the SULT1 family are capable of sulfating tocopherols and CEHCs (Fig. 3) . Our results confirm that large amounts of -CEHC conjugates in the plasma and urine can be attributed to the extensive sulfation activity of SULT1 isoforms present in different cells in the body. It has been found that SULT 1 families are expressed in the liver, lung, kidney, and intestine in a number of studies. 8) In these organs, the amounts of sulfated tocopherol metabolites such as -CEHC sulfate must be regulated by SULT1A1, SULT1B1, SULT1C4, and SULT1E1. The results obtained here underscore the previous finding that the rate of urinary excretion of -CEHC is much lower than that of -CEHC. Although it remains to be clarified, the sulfation of -CEHC by relevant SULTs might regulate physiological functions, such as natriuresis and the anti-inflammatory effect.
With regard to the latter, recent studies suggest that sulfation can not only serve in the detoxification and regulation of hormones and other key endogenous or xenobiotic compounds, but can also play a role in additional functions, as in the case for pregnenolone sulfate, dehydroepiandrosterone sulfate, etc. 30) Additional work is warranted in order to identify novel functions of sulfated vitamin E metabolites. The relative amount of 35 S-sulfated product present in the labeling medium of A549 cells was subjected to TLC, followed by auto radiographic analysis using Fujifilm FLA-3000. The results shown represent means AE SD (n ¼ 3). Tocopherols are metabolized via !-hydroxylation, followed by -oxidation. 4, 28, 29) Based on the results of the present study, sulfation might occur in parallel with -oxidation.
27) The sulfation of tocopherol metabolites is catalyzed mainly by members of SULT1 subfamilies. The steps indicated by dotted arrows remain to be confirmed.
